Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Start-Up Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

Add companies to Watchlist

45 companies were selected
Add Watchlist note (optional)

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Hey #USER_FULLNAME#!
Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

The invitation to claim the profile was originally sent to

or  

Hey #USER_FULLNAME#!
Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

Suggest Edits

Let us know what you think is inaccurate or missing.
We will check it out and update the profile if needed.

Claim Profile

Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

Already have an account? Login

Verify your email

We’ve sent a verification link to email@email.com
Reset password
Don't have an account? Sign up

Check your mailbox

We sent you an email with further instructions to
email@email.com

Do not forget to check your spam folder

Didn’t get the email? Resend email or Contact us

Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

Save Search

Search must have a valid name.
Search Was Saved

Rename Search

Search must have a valid name.
Search Was Saved
Delete Saved Search Confirmation
search will be permanently removed from Finder.
News Analysis
Home > Companies > Silenseed
Claimed by owner Last Update 10.9.2023 Suggest Edits Claim Profile
Claimed by owner
Silenseed logo

Silenseed

RNAi-based Cancer Drugs and Delivery Systems

Hidden Profile undefined terms of use
Silenseed
About
Lifecycle
News
Gallery
www.calcalistech.com
Oct 5, 2021
Silenseed signs $7.8 million agreement with GIBF to create Chinese subsidiary
#Investment #Partners
nocamels.com
Aug 1, 2017
Israeli Biomed Firm Silenseed Raises $10M
#Investment
en.globes.co.il
Jul 30, 2017
Silenseed Phase II pancreatic cancer drug trial to begin
#Investment
www.nasdaq.com
Nov 10, 2015
Silenced: RNA biotech Silenseed withdraws $35 million IPO
www.nasdaq.com
Jun 13, 2014
Cancer biotech Silenseed files for a $35 million IPO

About

Silenseed is a clinical-stage biopharmaceutical company that is using a proprietary RNA interference strategy to develop cancer drugs and delivery systems designed to effectively penetrate and treat malignant solid tumors.

The companys novel drugs, combined with the local drug eluter (LODER) delivery system, have the potential to become an effective treatment for solid tumor cancers. Silenseed is focused on treatments for pancreatic cancer, prostate cancer, and certain brain cancers.

Silenseed has completed a phase 2a clinical study for pancreatic cancer which showed promising results.

Founded

Business models

B2B

Employees

Product stage

Primary Sector

Life Sciences & HealthTech

Products

siG12D-LODER, Prostate-LODER, GBM-LODER, Protact, KRAS-LODER

Geographic markets

United States, China

Funding

Total Funding

$18.3M

Last Funding

$7.8M

Funding Stage

Total Rounds

4

Investors

4

News

  (5)
www.calcalistech.com
Oct 5, 2021
Silenseed signs $7.8 million agreement with GIBF to create Chinese subsidiary
#Investment #Partners
nocamels.com
Aug 1, 2017
Israeli Biomed Firm Silenseed Raises $10M
#Investment
en.globes.co.il
Jul 30, 2017
Silenseed Phase II pancreatic cancer drug trial to begin
#Investment
www.nasdaq.com
Nov 10, 2015
Silenced: RNA biotech Silenseed withdraws $35 million IPO
www.nasdaq.com
Jun 13, 2014
Cancer biotech Silenseed files for a $35 million IPO

The Team

(3)
ASP
Amotz Shemi, PhD
Co-Founder & CEO
EGM
Eitan Galun, MD
Co-Founder
EG
Eran Geffen
VP Business Development

Connect with

What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300

Sending invitation...

Company Lifecycle

Event View
Timeline View

Public Offerings & Exits

Private Equity Funding

Seed
$500K
Apr 2014
1 Investors
$500K
Undisclosed Round
$10M
Aug 2017
2 Investors
$10M
Undisclosed Round
$7.8M
Oct 2021
1 Investors
$7.8M

Non-Equity Funding

Grant
Undisclosed
Sep 2009
1 Grantors
Undisclosed

Locations

Israel

HaMa'ayan Street 2, Modi'in-Maccabim-Re'ut, Israel

Offices Abroad

Sector

Life Sciences & HealthTech
Pharma & Biomedicine
Discovery & Development
Drug Delivery

Core Technology

Biologicals
Cells

Target Customer

Healthcare & Life Sciences
Life Sciences
Pharmaceuticals

Tags

(10)

Locations

Israel

HaMa'ayan Street 2, Modi'in-Maccabim-Re'ut, Israel

Offices Abroad

Notes

Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
  • Get unlimited search results
  • Save to custom lists - Watchlists
  • Get notified with news and updates
  • Connect with people
And much more...
I already have access,
I already have access,